Shareholder Push for STAAR Board Changes
Update: 2025-11-11
Description
STAAR Surgicals major shareholder, Broadwood Partners, is advocating for significant changes to the companys board, following the revised merger deal with Alcon. Neal Bradsher, Broadwoods founder, criticizes the boards decision to sell STAAR to Alcon for $28 per share, citing concerns about the timing, process, and price. He also calls for new, independent directors, suggesting Christopher Wang, founder of Yunqi Capital, as a potential candidate. STAARs shareholder meeting has been postponed to December 19th, with a new go-shop period until December 6th.
The Daily News Now! — Every city. Every story. AI-powered.
Hosted on Acast. See acast.com/privacy for more information.
Comments
In Channel
Download from Google Play
Download from App Store
United States00:00
00:00
1.0x
